273 related articles for article (PubMed ID: 33283783)
21. Minimum Transendothelial Electrical Resistance Thresholds for the Study of Small and Large Molecule Drug Transport in a Human in Vitro Blood-Brain Barrier Model.
Mantle JL; Min L; Lee KH
Mol Pharm; 2016 Dec; 13(12):4191-4198. PubMed ID: 27934481
[TBL] [Abstract][Full Text] [Related]
22. In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells.
Kokubu Y; Yamaguchi T; Kawabata K
Biochem Biophys Res Commun; 2017 Apr; 486(2):577-583. PubMed ID: 28336435
[TBL] [Abstract][Full Text] [Related]
23. A Simplified, Fully Defined Differentiation Scheme for Producing Blood-Brain Barrier Endothelial Cells from Human iPSCs.
Neal EH; Marinelli NA; Shi Y; McClatchey PM; Balotin KM; Gullett DR; Hagerla KA; Bowman AB; Ess KC; Wikswo JP; Lippmann ES
Stem Cell Reports; 2019 Jun; 12(6):1380-1388. PubMed ID: 31189096
[TBL] [Abstract][Full Text] [Related]
24. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.
Raut S; Patel R; Al-Ahmad AJ
Fluids Barriers CNS; 2021 Jan; 18(1):3. PubMed ID: 33413468
[TBL] [Abstract][Full Text] [Related]
25. Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties.
Stebbins MJ; Gastfriend BD; Canfield SG; Lee MS; Richards D; Faubion MG; Li WJ; Daneman R; Palecek SP; Shusta EV
Sci Adv; 2019 Mar; 5(3):eaau7375. PubMed ID: 30891496
[TBL] [Abstract][Full Text] [Related]
26. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model.
Clark PA; Al-Ahmad AJ; Qian T; Zhang RR; Wilson HK; Weichert JP; Palecek SP; Kuo JS; Shusta EV
Mol Pharm; 2016 Sep; 13(9):3341-9. PubMed ID: 27421304
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Glycogen Synthase Kinase 3ß Enhances Functions of Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells in the Blood-Brain Barrier.
Yamaguchi T; Nishijima M; Kawabata K
Biol Pharm Bull; 2022; 45(10):1525-1530. PubMed ID: 36184511
[TBL] [Abstract][Full Text] [Related]
29. Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.
Goldeman C; Ozgür B; Brodin B
Fluids Barriers CNS; 2020 Apr; 17(1):32. PubMed ID: 32321539
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronan impairs the barrier integrity of brain microvascular endothelial cells through a CD44-dependent pathway.
Al-Ahmad AJ; Patel R; Palecek SP; Shusta EV
J Cereb Blood Flow Metab; 2019 Sep; 39(9):1759-1775. PubMed ID: 29589805
[TBL] [Abstract][Full Text] [Related]
31. Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier.
Mochizuki T; Mizuno T; Kurosawa T; Yamaguchi T; Higuchi K; Tega Y; Nozaki Y; Kawabata K; Deguchi Y; Kusuhara H
Drug Metab Dispos; 2021 Jan; 49(1):3-11. PubMed ID: 33144341
[TBL] [Abstract][Full Text] [Related]
32. Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.
Nishihara H; Gastfriend BD; Soldati S; Perriot S; Mathias A; Sano Y; Shimizu F; Gosselet F; Kanda T; Palecek SP; Du Pasquier R; Shusta EV; Engelhardt B
FASEB J; 2020 Dec; 34(12):16693-16715. PubMed ID: 33124083
[TBL] [Abstract][Full Text] [Related]
33. Advances in blood-brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure.
Brown JA; Faley SL; Shi Y; Hillgren KM; Sawada GA; Baker TK; Wikswo JP; Lippmann ES
Fluids Barriers CNS; 2020 Jun; 17(1):38. PubMed ID: 32493346
[TBL] [Abstract][Full Text] [Related]
34. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
35. Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions.
Uwamori H; Ono Y; Yamashita T; Arai K; Sudo R
Microvasc Res; 2019 Mar; 122():60-70. PubMed ID: 30472038
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype.
Matsuo K; Engelhardt B; Nishihara H
J Vis Exp; 2023 May; (195):. PubMed ID: 37318257
[TBL] [Abstract][Full Text] [Related]
37. Real-time acquisition of transendothelial electrical resistance in an all-human,
Maherally Z; Fillmore HL; Tan SL; Tan SF; Jassam SA; Quack FI; Hatherell KE; Pilkington GJ
FASEB J; 2018 Jan; 32(1):168-182. PubMed ID: 28883042
[TBL] [Abstract][Full Text] [Related]
38. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
39. Oxygen-Glucose Deprivation/Reoxygenation-Induced Barrier Disruption at the Human Blood-Brain Barrier is Partially Mediated Through the HIF-1 Pathway.
Page S; Raut S; Al-Ahmad A
Neuromolecular Med; 2019 Dec; 21(4):414-431. PubMed ID: 30911877
[TBL] [Abstract][Full Text] [Related]
40. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells.
Qian T; Maguire SE; Canfield SG; Bao X; Olson WR; Shusta EV; Palecek SP
Sci Adv; 2017 Nov; 3(11):e1701679. PubMed ID: 29134197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
